Literature DB >> 15227783

High level of resistance to metronidazole and clarithromycin in Helicobacter pylori isolated from pediatric patients in Poland (1997-2001).

G Gościniak1, B Iwańczak, A Przondo-Mordarska, J Grabińska, F Iwańczak.   

Abstract

Resistance to metronidazole (Met), clarithromycin (Cla) and amoxycillin (Amo) was examined using H. pylori isolates from child patients before and after treatment in the period 1997-2001. The rate of Met and Cla resistance before treatment was 35.2 and 8.6%, respectively. Six weeks after treatment 48.4% of the isolated strains were resistant to Met and 17.6% to Cla. The highest rate of resistance to both antibiotics was determined in 2001 (before treatment, 46 and 15%, respectively, and after treatment, 57.8 and 26.3%, respectively). All the strains were susceptible to Amo. Strains resistant to Met were detected more frequently in girls than in boys.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15227783     DOI: 10.1007/bf02931386

Source DB:  PubMed          Journal:  Folia Microbiol (Praha)        ISSN: 0015-5632            Impact factor:   2.099


  16 in total

1.  Secondary resistance among 554 isolates of Helicobacter pylori after failure of therapy.

Authors:  M Heep; M Kist; S Strobel; D Beck; N Lehn
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2000-07       Impact factor: 3.267

2.  Susceptibilities of Helicobacter pylori strains isolated from children with gastritis to selected antibiotics.

Authors:  A F Mentis; E Roma; A Pangalis; E Katsiyiannakis
Journal:  J Antimicrob Chemother       Date:  1999-11       Impact factor: 5.790

3.  High levels of resistance to metronidazole and clarithromycin in Helicobacter pylori strains in children.

Authors:  N Kalach; M Bergeret; P H Benhamou; C Dupont; J Raymond
Journal:  J Clin Microbiol       Date:  2001-01       Impact factor: 5.948

4.  Primary and combined resistance to four antimicrobial agents in Helicobacter pylori in Sofia, Bulgaria.

Authors:  Ludmila Boyanova; Irina Stancheva; Zoya Spassova; Nikolai Katzarov; Ivan Mitov; Radka Koumanova
Journal:  J Med Microbiol       Date:  2000-05       Impact factor: 2.472

5.  High prevalence of Helicobacter pylori infection with dual resistance to metronidazole and clarithromycin in Hong Kong.

Authors:  W H Wang; B C Wong; A K Mukhopadhyay; D E Berg; C H Cho; K C Lai; W H Hu; F M Fung; W M Hui; S K Lam
Journal:  Aliment Pharmacol Ther       Date:  2000-07       Impact factor: 8.171

Review 6.  Review article: Helicobacter pylori infection from pathogenesis to treatment--a critical reappraisal.

Authors:  D Vaira; J Holton; C Ricci; C Basset; L Gatta; F Perna; A Tampieri; M Miglioli
Journal:  Aliment Pharmacol Ther       Date:  2002-07       Impact factor: 8.171

7.  Helicobacter pylori in children and adolescents: increase of primary clarithromycin resistance, 1997-2000.

Authors:  J Crone; G Granditsch; W-D Huber; C Binder; A Innerhofer; G Amann; A M Hirschl
Journal:  J Pediatr Gastroenterol Nutr       Date:  2003-03       Impact factor: 2.839

8.  Amoxycillin resistance is one reason for failure of amoxycillin-omeprazole treatment of Helicobacter pylori infection.

Authors:  M P Dore; A Piana; M Carta; A Atzei; B M Are; I Mura; G Massarelli; A Maida; A R Sepulveda; D Y Graham; G Realdi
Journal:  Aliment Pharmacol Ther       Date:  1998-07       Impact factor: 8.171

9.  Results of a multicentre European survey in 1991 of metronidazole resistance in Helicobacter pylori. European Study Group on Antibiotic Susceptibility of Helicobacter pylori.

Authors: 
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-09       Impact factor: 3.267

10.  Clarithromycin resistance among Helicobacter pylori strains isolated from children: prevalence and study of mechanism of resistance by PCR-restriction fragment length polymorphism analysis.

Authors:  Teresa Alarcón; Alba E Vega; Diego Domingo; Maria Josefa Martínez; Manuel López-Brea
Journal:  J Clin Microbiol       Date:  2003-01       Impact factor: 5.948

View more
  3 in total

1.  In vitro and in vivo activities of HPi1, a selective antimicrobial against Helicobacter pylori.

Authors:  Ekaterina Gavrish; Binu Shrestha; Chao Chen; Ida Lister; E Jeffrey North; Lei Yang; Richard E Lee; Angel Han; Bronwyn Williams; David Charnuska; Ken Coleman; Kim Lewis; Michael D LaFleur
Journal:  Antimicrob Agents Chemother       Date:  2014-03-31       Impact factor: 5.191

2.  Antibacterial resistance and the success of tailored triple therapy in Helicobacter pylori strains isolated from Slovenian children.

Authors:  Tita Butenko; Samo Jeverica; Rok Orel; Matjaž Homan
Journal:  Helicobacter       Date:  2017-06-27       Impact factor: 5.753

3.  Efficacy of Phenotype-vs. Genotype-Guided Therapy Based on Clarithromycin Resistance for Helicobacter pylori Infection in Children.

Authors:  Yan Feng; Wenhui Hu; Yuhuan Wang; Junping Lu; Ye Zhang; Zifei Tang; Shijian Miao; Ying Zhou; Ying Huang
Journal:  Front Pediatr       Date:  2022-03-29       Impact factor: 3.418

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.